Oncolytic viral therapies.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

58 citing papers in PubMed, 127 citations in OpenAlex.

1. Oncolytic viruses: advanced strategies in cancer therapy.Signal transduction and targeted therapy · 2026
   Review
2. How Advanced are Cancer Immuno-Nanotherapeutics? A Comprehensive Review of the Literature.International journal of nanomedicine · 2023
   Review
3. Therapeutic Applications for Oncolytic Self-Replicating RNA Viruses.International journal of molecular sciences · 2022
   Review
4. Interventional oncology: new techniques and new devices.The British journal of radiology · 2022
   Review
5. Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives.Cancers · 2021
   Review
6. Combination of Mesenchymal Stem Cell-Delivered Oncolytic Virus with Prodrug Activation Increases Efficacy and Safety of Colorectal Cancer Therapy.Biomedicines · 2021
   Article
7. Electrical Stimulation for Immune Modulation in Cancer Treatments.Frontiers in bioengineering and biotechnology · 2021
   Review
8. The Oncolytic Virus in Cancer Diagnosis and Treatment.Frontiers in oncology · 2020
   Review
9. Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study.Laryngoscope investigative otolaryngology · 2019
   Article
10. Analysis of a Multiple Delays Model for Treatment of Cancer with Oncolytic Virotherapy.Computational and mathematical methods in medicine · 2019
    Article
11. Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy.Expert review of vaccines · 2018
    Review
12. The emerging role of oncolytic virus therapy against cancer.Chinese clinical oncology · 2018
    Review
13. New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy.Biologics : targets & therapy · 2018
    Review
14. Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives.Frontiers in immunology · 2017
    Review
15. Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.Frontiers in oncology · 2017
    Review
16. Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy.Journal for immunotherapy of cancer · 2016
    Article
17. Oncolytic adenovirus-mediated short hairpin RNA targeting MYCN gene induces apoptosis by upregulating RKIP in neuroblastoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
18. MiRNA inhibition in tissue engineering and regenerative medicine.Advanced drug delivery reviews · 2015
    Review
19. Adenovirus vectors for gene therapy, vaccination and cancer gene therapy.Current gene therapy · 2013
    Review
20. Is cancer gene therapy an empty suit?The Lancet. Oncology · 2013
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as